Fri 19'th Jan 2018
Proteon Therapeutics Stock Analysis
Technical stock analysis for Fri 19'th Jan 2018
|Shorts||0.36% ( 2017-12-29 )|
Proteon Therapeutics lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7% during the next 3 months and, with 90% probability hold a price between $1.76 and $3.06 at the end of this period.
Proteon Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $2.41 and $1.98. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday January 18, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".
Relative Strength Index (RSI)
RSI14 is 65 and the stock is currently not being overbought or oversold
Support & Resistance
Proteon Therapeutics finds support from accumulated volume at $2.40. On the upside the stock meets some resistance just above today's level from accumulated volume at $2.50 and $2.85.
The stock is about to test the resistance from accumulated volume at $2.50 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.25 between high and low, or 10.87%. For the last week the stock has had a daily average volatility of 17.18%.
Our recommended stoploss: $2.27 (-7.41%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Buy PRTO CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder